Before you watch this webinar

Enhancing your learning experience begins with understanding you better. Collecting data enables us to tailor our educational content specifically for our audience. Discover more about how we handle your information in our Privacy Policy.

Marketing Preferences

Event

Hidden disorders, emerging solutions - the evolving agenda for rare neurological conditions


08 Oct 2026 • 15:30 - 17:20

Our sponsor
AstraZeneca logo

This webinar has received sponsorship from AstraZeneca. The sponsor has had no input into the educational content or organisation of the session.

Please note that all session and slide content are the views of the speakers, not the Neurology Academy. The content of the recording is the speaker’s personal opinion at the time of recording. Due to the everchanging situation, advice given at the time of recording is subject to change
Neurology Academy session

A focused, high-impact webinar exploring how the 2026 England Rare Disease Action Plan will reshape neurology services. With a new national commitment to tackling health inequalities, this session will highlight what the updated agenda means for clinicians,
service leaders and those working across rare neurological pathways.

The webinar aims to provide a clear, actionable overview of how the rare disease agenda is evolving and what can be done today to deliver more equitable, timely and consistent care for people living with rarer neurological conditions.

Session 1

Unpacking the 2026 England Rare Disease Action Plan for rare neurological conditions
Georgina Carr, CEO, Neurological Alliance

Objectives

  • Outline the key points from the Action Plan relevant to neurology.
  • Detail how rarer neurological conditions are represented within the plan.
  • Highlight areas requiring further focus to reduce existing service deficits.
Session 2

Tackling unwarranted variation
Dr Vasantha Gowda, consultant paediatric neurologist, Guy's and St Thomas' NHS Foundation Trust

Objectives

  • Identify where inequity and unwarranted variation arise in rare disease recognition and diagnosis.
  • Detail the challenges encountered during investigation and referral.
  • Highlight how screening programmes and the evolving treatment landscape have influenced practice in the management of babies with SMA Type 1.
Session 3

Practical actions to reduce delay and variation in rarer neurological conditions
Dr Lucy McKay, CEO, Medics for Rare Disease

Objectives

  • Highlight practical actions that can reduce delays and variation in care.
  • Explore how adopting a red-flag mindset can improve recognition and management.
  • Demonstrate the benefits of a minimum referral dataset alongside clear safety-netting and escalation pathways within clinics.
Presentation slides | Georgina Carr

Presentation slides | Dr Vasantha Gowda

Presentation slides | Dr Lucy McKay

Our sponsor
AstraZeneca logo

This webinar has received sponsorship from AstraZeneca. The sponsor has had no input into the educational content or organisation of the session.

CPD accreditation

Hidden disorders, emerging solutions - the evolving agenda for rare neurological conditions' has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 1 category 1 (external) CPD credit(s).

Uniquely practical education, producing specialist clinical leaders transforming local healthcare

Neurology Academy is an innovative educational provider for healthcare professionals including consultants, specialist nurses, pharmacists, therapists and other allied health professionals. Our courses are developed by practicing specialists who combine their experience and expertise into case-based learning designed to create specialists in their field with confidence in effecting change.